Central
venous catheters
consist of a long, thin tube that is inserted into a large vein to
deliver medication, nutrition, intravenous fluids, and cancer
medications. Different types of central venous catheters can be
utilized by patients according to the duration of the treatment,
which includes tunneled central venous catheters (CVC) and implanted
ports for long term use, peripherally inserted central catheter
(PICC) for intermediate term and nontunneled CVC for short term use.
Market Dynamics
Increasing prevalence of renal diseases is a major factor driving
central venous catheter market growth. According to the research
survey done by U.S. Renal Data System (USRDS), in 2017, around
440,000 patients are living with End-Stage Renal Disease (ESRD) in
the U.S and require hemodialysis for survival annually. Moreover,
introduction of innovative products and increasing requirement of
long-duration IV therapies such as chemotherapy is expected to boost
the market growth. For instance, in May, 2018, Pursuit Vascular,
Inc., received U.S. Food and Drug Administration (FDA) clearance for
a broader indication of its ClearGuard HD caps to include reduction
in the incidence of central-line associated bloodstream infection
(CLABSI) in hemodialysis patients with central venous catheters
(CVCs).
Download
PDF Brochure @
https://www.coherentmarketinsights.com/insight/request-pdf/2400
Increasing prevalence of cancer and renal diseases is expected to
propel growth of central venous catheter market
Central venous catheterization is used for chemotherapy
administration, total parenteral nutrition, administration of
intravenous fluids, administration of blood and platelet
transfusions, and other uses. High prevalence of cancer is expected
to propel demand for central venous catheterization, which in turn is
expected to drive the market growth. According to the World Health
Organization (WHO), 2012, cancer is the second leading cause of
morbidity and mortality worldwide, with around 14 million new cases
registered in 2012 and in 2015, cancer was responsible for 8.8
million deaths worldwide. Moreover, WHO stated that the number of new
cases is expected to rise by around 70% by 2030.
Similarly, according to the study by University of California, 2014,
around 2 million people worldwide are affected by end stage renal
disease (ESRD) and the number of patients diagnosed with the disease
is expected to increase at a rate of 5-7% annually.
Increasing adoption of central venous catheters in North America
is expected to bolster the market growth
North America holds dominant position in the global central venous
catheter market, owing to high availability of catheters in medical
settings. According to the survey by PavMed, 2016, around 7 million
central vascular access devices are utilized annually in the U.S.,
which includes 400-500,000 implantable ports. Increasing prevalence
of cancer in the region is also expected to boost the market growth.
According to the American Cancer Society, 2017, cancer is the second
most common cause of death in the U.S., which accounts for nearly 1
out of every 4 deaths.
Key Players
Major players operating in the global central venous catheter market
include, AngioDynamics, Inc., C. R. Bard, Inc., Teleflex
Incorporated, B. Braun Melsungen AG, Medtronic Plc., Vygon Ltd., Cook
Medical, Inc., Argon Medical Devices, Inc., ICU Medical, Inc., and
Theragenics Corporation.
To
Avail Discount on This Report @
https://www.coherentmarketinsights.com/insight/request-discount/2400
Also,
Coherent Market Insights has a proprietary database of pipeline
biologics and biosimilars, called PHASE-XS.
This database provides analytical data in addition to the clinical
information of ongoing trials for biologics and biosimilars. An
amalgamation of more than 30 parameters, PHASE-XS
helps biotechnology and pharmaceutical companies to analyze the
market trend, competition, and market potential. For more information
or to access this database, kindly click on the below link or contact
at sales@coherentmarketinsights.com
About Coherent Market Insights:
Coherent Market Insights is a prominent market research and
consulting firm offering action-ready syndicated research reports,
custom market analysis, consulting services, and competitive analysis
through various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave,
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
No comments:
Post a Comment